Carcinoma: all 6,715 studies
Page 40 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.
- Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03766178Phase 2
- Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior TherapyCompletedNCT03762564Phase 2
- IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid TumorsCompletedNCT03758781Phase 1
- TAK-659 and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT03756818Phase 1
- Perfusion and Dual Energy Computer Tomography in Hepatocellular CarcinomaStatus unknownNCT03754192Not applicable
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)CompletedNCT03752398Phase 1
- Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03751436Phase 1
- Natural History Study of Children and Adults With Fibrolamellar Hepatocellular CarcinomaWithdrawnNCT03748927
- PD-L1 Expression in Japanese Renal Cell Carcinoma PatientsCompletedNCT03748901
- Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )CompletedNCT03748134Phase 3
- Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCCWithdrawnNCT03746249Phase 2
- UTOLA: UTerin OLAparibCompletedNCT03745950Phase 2
- Paclitaxel and TAK-228 in Urothelial CarcinomaStatus unknownNCT03745911Phase 2
- Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.CompletedNCT03744585
- SCT200 Injection in Patients With Head and Neck Squamous Cell CarcinomaStatus unknownNCT03744208Phase 2
- Study Assessing the Safety and Performance of Smart Matrix®Status unknownNCT03742726Not applicable
- Evaluation of Diagnostic Accuracy of CEUS for HCC DiagnosisStatus unknownNCT03742453Not applicable
- Study of TG02 Citrate in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT03738111Phase 1
- A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal CarcinomaStatus unknownNCT03736330Phase 2
- A Real World Study of Apatinib in Treatment of Patients With Gastric CarcinomaStatus unknownNCT03735511
- Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell CarcinomaStatus unknownNCT03734614
- Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCCStatus unknownNCT03734068
- Pembrolizumab in Treating Participants With Recurrent Ovarian CancerActive, not recruitingNCT03732950Phase 2
- Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular CarcinomaStatus unknownNCT03732547Phase 2
- Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TAREStatus unknownNCT03731910Not applicable
- Irradiation Stent Placement Plus TACE for HCC and PVTTStatus unknownNCT03730675Not applicable
- Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT03727594
- Apatinib for Advanced Lung Squmamous CarcinomaStatus unknownNCT03725423Phase 4
- Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInomaCompletedNCT03723941Phase 3
- GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03723343
- SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After SurgeryStatus unknownNCT03722875Not applicable
- Comparison of Blood Loss in Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Periampullary CarcinomaStatus unknownNCT03722732Not applicable
- The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LCStatus unknownNCT03722628
- Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACEWithdrawnNCT03722498Phase 2
- Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer PatientsTerminatedNCT03720158Not applicable
- Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell CarcinomaCompletedNCT03719924Phase 2
- Sym004 Versus TAS-102 in Patients With mCRCWithdrawnNCT03717038Phase 3
- Nipple Aspirate Fluid in Detecting Breast CancerCompletedNCT03715959Not applicable
- A Study of IO103 in Montanide Adjuvant for Basal Cell CarcinomaCompletedNCT03714529Phase 2
- NEUWAVE Flexible Probe Study #2WithdrawnNCT03713099Not applicable
- Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid CarcinomaStatus unknownNCT03709953Phase 2
- Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate CancerWithdrawnNCT03709550Phase 1/2
- Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT03708822Phase 2
- Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective StudyStatus unknownNCT03708705
- Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT03708224Phase 2
- Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03707509Phase 3
- Direct Acting Antiviral-Post Authorization Safety StudyCompletedNCT03707080
- Hepatocellular Carcinoma in HIV-infected Individuals in Asian PopulationCompletedNCT03702998
- Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder CarcinomaStatus unknownNCT03702491Phase 2
- Compassionate Use Individual Request Program for GSK525762 in NUT Midline CarcinomaNo longer availableNCT03702036
- Demethylated Drug in the Treatment of Nasopharyngeal CarcinomaStatus unknownNCT03701451Phase 1/2
- Early Detection of Head and Neck Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell CarcinomaStatus unknownNCT03700398Not applicable
- Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCCCompletedNCT03699657Not applicable
- Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCCCompletedNCT03699579
- Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal OriginStatus unknownNCT03699332Phase 1/2
- A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UKCompletedNCT03696407
- A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell CarcinomaWithdrawnNCT03693573Phase 3
- Role of Geminin and Mcm-2 in Prognosis of Renal Cell CarcinomaStatus unknownNCT03692533Not applicable
- INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell CarcinomaTerminatedNCT03692338Not applicable
- Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT03691376Phase 1
- Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion TherapyStatus unknownNCT03689556
- Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT03685695Phase 2
- Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid TumorsTerminatedNCT03684785Phase 1/2
- CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)WithdrawnNCT03682744Phase 1
- A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial CarcinomaStatus unknownNCT03676946Phase 1/2
- Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCCWithdrawnNCT03673735Phase 3
- Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTCCompletedNCT03673072Phase 3
- Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCCStatus unknownNCT03672305Early Phase 1
- Surgical Treatment of Pancreatic RCC MetastasesCompletedNCT03670992
- Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast CancerCompletedNCT03669952
- Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal CarcinomaStatus unknownNCT03668730Phase 2
- S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03668366Phase 2
- Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular CarcinomaStatus unknownNCT03668158
- Nimotuzumab for Recurrent Nasopharyngeal CarcinomaStatus unknownNCT03666221Phase 2
- A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has SpreadCompletedNCT03663946
- A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular CarcinomaCompletedNCT03663114
- Ablative Chemoembolization for Unresectable and Large Hepatocellular CarcinomaTerminatedNCT03662841Not applicable
- Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell CarcinomaCompletedNCT03660449Phase 2
- EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral DrugStatus unknownNCT03656965Phase 3
- APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCCTerminatedNCT03655613Phase 1/2
- Anatomy-based Resection or Margin-based Resection for Hepatocellular CarcinomaStatus unknownNCT03652896Not applicable
- The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular CarcinomaStatus unknownNCT03652467Phase 1
- A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesCompletedNCT03652077Phase 1
- Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined ChemotherapyStatus unknownNCT03647527
- DKN-01 Inhibition in Advanced Liver CancerStatus unknownNCT03645980Phase 1/2
- Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line TreatmentTerminatedNCT03644511
- Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03639467Phase 1/2
- Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)CompletedNCT03639168Phase 2
- Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid CarcinomaStatus unknownNCT03636945Not applicable
- TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan CriterialCompletedNCT03636620Phase 3
- Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular CarcinomaWithdrawnNCT03636607Not applicable
- A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver TransplantationWithdrawnNCT03634683Phase 1/2
- A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)Active, not recruitingNCT03634540Phase 2
- Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted VaccineCompletedNCT03633110Phase 1/2
- Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy VolunteersTerminatedNCT03630601Not applicable
- Computer-assisted Tumor Ablation for Patients With Liver CancerCompletedNCT03630068
- A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesCompletedNCT03629756Phase 1
- Blood Sample Collection to Evaluate Biomarkers for Hepatocellular CarcinomaCompletedNCT03628651
- A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.TerminatedNCT03628079Phase 1/2
- Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell CarcinomaActive, not recruitingNCT03624673Not applicable